Does Mounjaro Harm Eye Health? Long-Term Study Shows Diabetic Retinopathy Risk Actually Drops
Concerns that Eli Lilly’s popular weight-loss and diabetes treatment, Mounjaro, might exacerbate eye complications in diabetic patients appear to be...
Search results for "obesity treatment"
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval
Since the World Health Organization recommended the use of obesity medications for adults last December, the market is expected to heat up even...
The Surprising Life-Saving Potential of Weight Loss Meds in Diabetic Foot Care
GLP-1 receptor agonists (such as Wegovy and Ozempic), currently dominating the headlines as weight loss medications,...
'10kg Weight Loss' Pani Bottle, Yo-Yo After Stopping Wegovy
Travel YouTuber Pani Bottle confessed to experiencing a yo-yo effect. Pani Bottle recently posted a photo taken during...
Mild Cognitive Impairment Doesn’t Always Lead to Dementia—Early Diagnosis and Lifestyle Management Are Key
Sept. 21 marks Dementia Overcoming Day, a designated observance created to raise public awareness about preventing and...
When You Can’t Recall "Madeleine": Short Film Youngsikxty Spotlights Early Dementia Awareness
“Less ice in the oat latte… and, you know, that thing. What is it, the yellow round thing.
To Curb GLP-1 Misuse, Experts Urge Tracking Who Gets Prescribed Wegovy and Mounjaro—and Why
As the adoption of GLP-1 receptor agonist obesity medications such as Wegovy and Mounjaro accelerates, medical experts...
Metabolic Syndrome Linked to Precancerous Stomach Lesions Independent of H. pylori
Patients who receive clear Helicobacter pylori test results during routine health screenings may still face an elevated...
Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group
Samsung Biologics is proceeding with a 3 trillion won ($2.25 billion) rights offering, directing approximately 90% of...
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009
Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the...